r
c
l
e
n
f
crimeancongo
hemorrhag
fever
computeraid
vaccin
design
multiepitop
vaccin
b
r
c
crimeancongo
hemorrhag
fever
cchf
consid
one
major
public
health
concern
case
fatal
rate
current
effect
approv
vaccin
cchf
studi
use
computeraid
vaccin
design
approach
develop
first
multiepitop
recombin
vaccin
cchf
purpos
linear
bcell
tcell
bind
epitop
two
structur
glycoprotein
cchf
viru
includ
gc
gn
predict
epitop
studi
regard
antigen
allergen
hydrophob
stabil
toxic
popul
coverag
total
number
seven
epitop
includ
five
tcell
two
bcell
epitop
screen
final
vaccin
construct
final
vaccin
construct
compos
amino
acid
residu
organ
four
domain
includ
linear
bcell
tcell
epitop
cholera
toxin
bsubunit
ctxb
along
heat
labil
enterotoxin
iic
b
subunit
ltiic
adjuv
segment
join
use
appropri
linker
physicochem
properti
well
presenc
induc
epitop
propos
vaccin
also
check
determin
vaccin
stabil
solubl
abil
induc
cellmedi
immun
respons
structur
propos
vaccin
subject
predict
comput
bcell
epitop
molecular
dock
studi
mhci
ii
molecul
furthermor
molecular
dynam
stimul
perform
studi
vaccinemhc
complex
stabil
stimul
time
result
suggest
propos
vaccin
stabl
well
solubl
water
potenti
antigen
result
also
demonstr
vaccin
induc
humor
cellmedi
immun
respons
could
serv
promis
anticchf
vaccin
candid
crimeancongo
hemorrhag
fever
cchf
wide
spread
zoonot
viral
diseas
case
fatal
rate
caus
cchf
viru
cchfv
recent
drastic
increas
cchfv
infect
around
world
especi
eastern
mediterranean
region
cchfv
envelop
singlestrand
ambisens
sens
rna
viru
diamet
nm
belong
nairoviru
genu
bunyavirida
famili
includ
five
genera
viru
speci
viru
genom
organ
three
segment
includ
small
medium
larg
l
segment
encod
nucleoprotein
n
glycoprotein
gn
gc
rnadepend
rna
polymeras
rdrp
l
respect
unfortun
licens
vaccin
approv
target
therapi
prevent
treatment
cchf
although
support
care
ribavirin
help
lot
treat
diseas
despit
high
fatal
rate
widespread
distribut
lack
treatment
vaccin
cchf
limit
studi
diseas
understand
process
help
design
effect
vaccin
nowaday
due
rapid
develop
molecular
immunolog
determin
molecular
mechan
pathogenesi
much
research
aim
vaccin
design
differ
lethal
diseas
recent
effort
made
introduc
novel
vaccin
diseas
regard
garrison
et
al
develop
dna
vaccin
express
msegment
glycoprotein
precursor
gene
cchfv
abil
provok
strong
humor
immun
respons
prevent
cchf
lethal
studi
anim
model
anoth
report
dowal
et
al
develop
recombin
candid
vaccin
express
cchfv
nucleoprotein
immunogen
fail
creat
protect
diseas
kortekaa
colleagu
introduc
subunit
vaccin
abil
induc
high
level
humor
respons
protect
observ
mice
cchfv
challeng
infect
gener
vaccin
consid
effect
immun
induc
pathogen
well
activ
way
control
infecti
diseas
due
wide
varieti
extens
genet
variat
among
differ
cchfv
serotyp
convent
vaccin
platform
liveattenu
inactiv
vaccin
protect
person
differ
cchfv
strain
furthermor
drawback
associ
convent
vaccin
includ
weak
immun
multidos
administr
allergen
potenti
low
safeti
consequ
current
new
vaccin
platform
subunit
vaccin
dna
vaccin
multiepitop
vaccin
mev
highli
regard
among
due
high
specif
safeti
lowcost
product
mev
vaccin
attract
attent
commonli
mev
engin
base
domin
conserv
band
tcell
epitop
desir
antigen
without
potenti
igeepitop
accordingli
effect
mev
provid
effect
immun
differ
serotyp
pathogen
despit
mention
advantag
mev
poor
immunogen
consid
major
drawback
develop
mev
overcom
mention
blind
spot
use
natur
proteinbas
adjuv
diphtheria
toxin
dt
cholera
toxin
bsubunit
ctxb
heatlabil
enterotoxin
b
subunit
ltb
tolllik
receptor
tlr
ligand
final
construct
propos
vaccin
suggest
studi
ctxb
ltiic
select
protein
adjuv
ctxb
amino
acid
nontox
homopantamer
commerci
avail
membranebind
subunit
cholera
toxin
could
increas
homor
mocus
immun
respons
furthermor
ctxb
receptor
wide
express
plasma
membran
immun
cell
therefor
protein
highli
regard
suitabl
natur
adjuv
ltiic
member
type
ii
subfamili
ltb
compos
amino
acid
residu
moreov
ltiic
one
beststudi
type
ii
ltb
shown
enhanc
antigenspecif
cell
immun
respons
coadminist
model
antigen
protein
adjuv
increas
level
mean
antibodi
titer
gener
immun
memori
especi
cell
memori
seroconvers
rate
popul
adjuv
also
reduc
amount
antigen
vaccin
formul
well
permit
immun
fewer
dose
vaccin
biolog
activ
achiev
induc
multipl
chemokin
cytokin
bone
marrowderiv
dendrit
cell
bmdc
includ
keratinocytederiv
chemokin
kc
eotaxin
cytokin
cytokin
furthermor
activ
tolllik
receptor
tlr
signal
pathway
induc
proinflamm
cytokin
promot
infiltr
antigenpres
cell
apc
induct
antigenspecif
cell
mechan
action
protein
adjuv
associ
biolog
activ
furthermor
presenc
linear
conform
band
tcell
epitop
protein
adjuv
improv
immun
respons
main
antigen
experiment
determin
domin
epitop
evalu
potenti
vaccin
efficaci
tediou
costli
therefor
recent
comput
method
highli
consid
altern
complementari
approach
epitop
determin
vaccin
design
computeraid
vaccin
design
also
call
comput
immunolog
provid
integr
pipelin
map
potenti
band
tcell
epitop
allergen
site
studi
antigen
predict
hlaepitop
affin
thu
approach
could
reduc
time
cost
requir
vaccin
design
recent
decad
comput
design
epitopebas
vaccin
use
vaccin
develop
mani
infecti
diseas
even
cancer
purpos
recent
mani
bioinformat
tool
develop
facilit
develop
epitopebas
vaccin
bioinformat
comput
tool
provid
convert
largescal
immunolog
data
antigen
present
process
antigenantibodi
interact
antigen
determin
obtain
express
interpret
therefor
current
vaccin
design
process
especi
epitop
base
vaccin
develop
facilit
along
introduc
appli
bioinformat
tool
epitop
map
softwareweb
servic
protein
model
softwar
proteinproteinligand
interact
analysi
softwar
although
much
time
pass
sinc
introduct
first
report
comput
vaccin
design
recent
year
lot
progress
made
regard
subsequ
numer
vaccin
develop
base
comput
approach
includ
effici
vaccin
toxoplasma
gondii
rickettsia
prowazekii
streptococcu
pneumonia
leishmania
infantum
chlamydia
pneumonia
brucella
abortu
staphylococcu
aureu
escherichia
coli
vibrio
cholera
human
immunodefici
hepat
c
viru
mani
other
mani
empir
studi
efficaci
comput
design
vaccin
approv
common
procedur
silico
vaccin
design
use
previou
studi
procedur
includ
antigen
select
epitop
predict
vaccin
engin
vaccin
evalu
result
common
protocol
may
limit
drawback
inappropri
physicochem
properti
predict
epitop
final
construct
toxic
epitop
instabl
final
vaccin
unabl
effect
express
design
vaccin
desir
host
therefor
present
studi
use
special
multistep
procedur
decreas
mention
obstacl
protocol
linear
b
cell
epitop
select
base
antigen
allergen
toxic
water
solubl
decis
paramet
similarli
antigen
hydrophob
popul
coverag
allergen
consid
determin
paramet
tcell
epitop
predict
screen
epitop
merg
well
two
natur
adjuv
use
appropri
linker
organ
final
vaccin
construct
furthermor
efficaci
stabil
vaccin
evalu
set
bioinformat
approach
includ
molecular
dock
molecular
dynam
silico
clone
procedur
use
multiepitop
vaccin
develop
depict
fig
first
stage
studi
refer
amino
acid
sequenc
cchfv
protein
includ
nucleoprotein
glycoprotein
precursor
rnadepend
rna
polymeras
retriev
ncbi
http
wwwncbinlmnihgov
fasta
format
access
number
respect
addit
primari
amino
acid
sequenc
ctxb
ltiic
obtain
uniprot
http
wwwuniprotorg
access
entri
respect
also
threedimens
structur
mhci
ii
retriev
protein
data
bank
http
www
rcsborg
pdb
format
pdb
entri
respect
determin
conserv
level
viru
protein
differ
cchfv
serotyp
protein
blast
perform
http
blast
ncbinlmnihgovblastcgi
furthermor
determin
conserv
region
protein
sequenc
multipl
sequenc
align
perform
clustal
omega
server
http
wwwebiacuktool
msaclustalo
addit
antigen
cchfv
protein
evalu
use
vaxijen
server
http
wwwddgpharmfacnet
vaxijenvaxijenvaxijenhtml
predict
antigen
peptid
http
imedmeducmestoolsantigenicpl
final
conserv
antigen
protein
select
analysi
select
antigen
analyz
determin
antigen
region
conserv
domain
sequenc
featur
physicochem
properti
purpos
set
onlin
tool
includ
predict
antigen
peptid
http
imedmeducmestoolsantigenicpl
ncbi
conserv
domain
databas
http
wwwncbinlmnihgov
structurecddwrpsbcgi
uniprot
http
wwwuniprotorg
protparam
http
webexpasyorgprotparam
use
mhci
restrict
epitop
predict
use
server
http
default
paramet
server
use
special
matric
mhci
allel
similarli
mhcii
restrict
epitop
predict
propr
server
http
crddosddnetraghavapropr
threshold
server
use
special
matric
hladr
allel
cover
mhcii
molecul
express
antigen
present
cell
furthermor
predict
epitop
screen
base
antigen
hydrophob
allergen
popul
coverag
use
set
onlin
tool
includ
vaxijen
http
php
allertop
http
wwwpharmfacnetallertop
iedb
analysi
resourc
http
toolsiedborgpopul
respect
final
epitop
appropri
properti
select
vaccin
construct
linear
bcell
epitop
predict
carri
use
bcpred
server
http
ailabistpsuedubcpredpredicthtml
fix
length
epitop
amino
acid
predict
method
specif
server
predict
linear
bcell
epitop
use
svm
combin
subsequ
kernel
ssk
attitud
accuraci
furthermor
crossvalid
predict
epitop
predict
epitop
check
http
www
cbsdtudkservicesbepipr
svmtrip
http
sysbiounledu
svmtrippredictionphp
abcpr
http
crddosddnet
raghavaabcpredabcsubmissionhtml
later
highrank
share
bcell
epitop
select
studi
furthermor
bcell
epitop
evalu
term
antigen
allergen
toxic
solubl
use
vaxijen
algpr
http
crdd
osddnetraghavaalgpredsubmissionhtml
toxin
pred
http
crdd
osddnetraghavatoxinpr
pepcalc
http
pepcalccom
onlin
server
respect
final
predict
linear
bcell
epitop
appropri
properti
select
locat
vaccin
structur
determin
appropri
band
tcell
epitop
organ
final
vaccin
construct
purpos
screen
band
tcell
epitop
merg
use
gpgpgpg
amino
acid
linker
random
pattern
join
epitop
consid
multiepitop
segment
core
propos
vaccin
final
construct
propos
vaccin
prepar
merg
multiepitop
part
two
natur
adjuv
includ
ctxb
ltiic
n
c
termin
use
eaaak
linker
respect
furthermor
amino
acid
composit
physicochem
properti
propos
vaccin
includ
molecular
weight
isoelectr
point
net
charg
ph
estim
solubl
water
estim
halflif
mammalian
reticulocyt
instabl
index
determin
use
protparam
http
webexpasyorgcgibinprotparamprotparam
pepcalc
http
pepcalccom
secondari
structur
propos
vaccin
predict
use
prabi
server
http
npsaprabiibcpfrcgibinnpsaautomat
pl
secondari
structur
predict
method
method
use
possibl
pair
frequenc
within
window
amino
acid
residu
mean
accuraci
addit
threedimens
structur
vaccin
gener
use
itass
server
http
zhanglabccmbmedumicheduitass
itass
rank
approach
protein
structur
function
predict
reli
level
similar
input
avail
templat
structur
pdb
reduc
possibl
structur
mistak
predict
tertiari
structur
vaccin
refin
predict
model
done
use
server
http
addit
geometri
qualiti
vaccin
valid
base
ramachandran
plot
use
rapag
server
http
mordredbioc
camacukrapperrampagephp
zscore
prosa
server
http
prosaservicescamesbgacatprosaphp
also
errat
qualiti
factor
http
servicesmbiuclaeduerrat
conform
bcell
epitop
vaccin
model
predict
use
ellipro
server
http
toolsiedborgellipro
follow
epitop
predict
paramet
minimum
score
maximum
distanc
seven
angstrom
furthermor
induc
epitop
amino
acid
sequenc
vaccin
predict
use
ifnepitop
server
http
crddosddnetraghavaifnepitopescanphp
motif
svm
hybrid
predict
approach
valid
bind
affin
vaccin
mhci
mhcii
molecul
molecular
dock
perform
propos
candid
vaccin
pdb
entri
pdb
entri
molecular
dock
studi
carri
use
patchdock
server
http
patchdock
default
complex
type
cluster
rmsd
server
use
object
recognit
imag
segment
techniqu
algorithm
molecular
dynam
comput
approach
use
describ
properti
molecul
behavior
ligandreceptor
interact
solvat
stabil
fluctuat
well
conform
chang
molecul
present
studi
md
simul
perform
vaccinemhc
model
complex
use
namd
graphic
interfac
modul
incorpor
visual
molecular
dynam
vmd
ns
stimul
protein
structur
file
psf
complex
built
use
automat
psf
gener
modul
vmd
md
simul
done
npt
equival
condit
bar
k
use
access
psf
pdb
file
afterward
dcd
trajectori
file
gener
namd
final
md
simul
result
analyz
base
root
mean
squar
deviat
rmsd
radiu
gyrat
rg
clone
express
vaccin
suitabl
express
vector
amino
acid
sequenc
vaccin
model
back
translat
nucleotid
sequenc
use
gene
infin
server
http
www
geneinfinityorgsmssmsbacktranslationhtml
base
codon
usag
tabl
escherichia
coli
optim
dna
evalu
term
codon
adapt
index
cai
gc
content
codon
frequenc
distribut
cfd
use
genscript
rare
codon
analysi
tool
http
wwwgenscriptcomtoolsrarecodonanalysi
paramet
key
role
optim
protein
express
host
express
system
latest
step
restrict
site
dna
map
use
nebcutt
http
appropri
restrict
site
ad
optim
dna
design
effect
multiepitop
vaccin
cross
protect
cchfv
firstli
protein
encod
viru
studi
determin
conserv
protein
differ
serotyp
viru
end
protein
blast
done
result
protein
blast
cchfv
protein
summar
tabl
result
show
rna
polymeras
conserv
level
differ
cchfv
serotyp
furthermor
averag
antigen
vaxijen
score
protein
determin
result
demonstr
glycoprotein
precursor
highest
antigen
follow
rna
polymeras
nucleoprotein
respect
due
high
antigen
good
conserv
higher
exposur
probabl
immun
system
glycoprotein
precursor
select
analysi
vaccin
design
potenti
antigen
region
glycoprotein
precursor
sequenc
illustr
fig
result
show
antigen
determin
glycoprotein
result
also
confirm
six
region
glycoprotein
sequenc
includ
tabl
result
cchfv
protein
blast
antigen
predict
glycoprotein
precursor
highest
averag
antigen
vaxijen
score
sequenc
ident
glycoprotein
differ
serotyp
cchfv
least
valu
compar
studi
antigen
tabl
therefor
glycoprotein
n
glycoprotein
c
select
analysi
due
high
antigen
along
good
conserv
level
probabl
expos
immun
system
final
amino
acid
sequenc
glycoprotein
consid
input
analysi
final
vaccin
construct
order
predict
tcell
epitop
use
twostep
special
screen
briefli
mhci
ii
restrict
epitop
predict
rank
accord
score
use
propr
respect
total
number
mhci
restrict
epitop
predict
gc
gn
respect
predict
mhci
restrict
epitop
compar
mhcii
restrict
epitop
determin
share
epitop
next
step
share
epitop
gc
gn
select
screen
respect
tabl
final
epitop
abil
bind
mhci
ii
allel
along
high
antigen
hydrophob
popul
coverag
nonallergen
properti
consid
final
tcell
epitop
final
screen
total
number
three
two
tcell
epitop
determin
gc
gn
respect
tabl
predict
linear
bcell
epitop
antigen
perform
crosscheck
method
firstli
linear
bcell
epitop
form
gc
gn
predict
use
bcpred
total
number
six
epitop
predict
gc
gn
respect
furthermor
determin
share
epitop
increas
confid
bcpred
output
crosscheck
use
three
differ
server
includ
abcpr
svmtrip
tabl
sinc
mention
server
linear
bcell
epitop
predict
perform
differ
algorithm
sequenc
similar
score
predict
epitop
consid
decis
factor
screen
share
epitop
subsequ
epitop
high
score
sequenc
similar
use
server
select
final
screen
consid
mention
conclus
factor
five
epitop
select
antigen
screen
epitop
evalu
regard
antigen
allergen
toxic
solubl
hydrophil
defin
final
bcell
epitop
result
show
one
epitop
studi
antigen
tabl
appropri
properti
consid
final
bcell
epitop
vaccin
construct
base
immunoinformat
analysi
final
one
epitop
gc
gn
consid
linear
bcell
epitop
furthermor
five
epitop
mention
antigen
select
tcell
epitop
final
vaccin
compos
amino
acid
organ
four
domain
ctxb
ltiic
adjuv
linear
bcell
epitop
tcell
epitop
join
use
appropri
linker
graphic
diagram
vaccin
domain
structur
linker
site
design
depict
fig
furthermor
physicochem
properti
amino
acid
composit
final
construct
predict
use
protparam
pepcalc
result
reveal
vaccin
protein
kda
stabl
solubl
protein
pi
net
charg
estim
halflif
found
h
protein
halflif
defin
time
take
half
amount
protein
cell
disappear
synthesi
cell
therefor
halflif
provid
time
propos
chimer
protein
exposur
immun
system
final
amino
acid
sequenc
amino
acid
composit
vaccin
depict
fig
secondari
structur
final
vaccin
construct
predict
use
gor
iv
method
basi
amino
acid
sequenc
protein
result
show
total
amino
acid
organ
alpha
helix
extend
strand
random
coil
respect
fig
furthermor
primari
model
propos
vaccin
predict
itass
onlin
server
ten
best
thread
templat
select
pdb
entri
local
metathreadingserv
program
model
propos
vaccin
final
top
five
model
protein
vaccin
suggest
cscore
respect
cscore
defin
rang
usual
higher
score
indic
model
higher
confid
accordingli
model
cscore
select
analysi
select
model
vaccin
subject
refin
process
server
purpos
whole
protein
structur
refin
includ
secondari
structur
element
loop
region
protein
sidechain
refin
select
refin
model
server
base
five
factor
includ
score
gdtt
gdtha
rmsd
rwplu
molprob
indic
potenti
energi
score
rwplu
similar
score
gdtt
gdtha
divis
score
physic
realism
score
respect
consequ
refin
model
appropri
properti
select
evalu
concern
mention
factor
tabl
furthermor
geometr
qualiti
primari
refin
model
evalu
appli
ramachandran
plot
errat
qualiti
factor
prosa
zscore
result
show
raw
model
residu
locat
favor
allow
outlier
region
respect
fig
refin
model
residu
posit
favor
allow
outlier
region
respect
fig
moreov
qualiti
factor
zscore
primari
model
refin
mention
paramet
determin
indic
improv
geometr
qualiti
primari
model
refin
refin
primari
model
propos
vaccin
illustr
fig
due
key
role
conform
bcell
epitop
well
induc
epitop
adapt
innat
immun
respons
protein
vaccin
subject
predict
mention
epitop
signatur
cytokin
innat
adapt
immun
system
abil
provok
antivir
immun
respons
protect
reinfect
releas
import
step
respons
induc
product
protect
virusneutr
igg
enhanc
magnitud
antivir
cytotox
lymphocyt
ctl
respons
predict
conform
bcell
epitop
structur
propos
vaccin
use
input
predict
probabl
conform
bcell
epitop
via
ellipro
total
number
seven
conform
bcell
epitop
predict
vaccin
includ
residu
residu
result
also
show
residu
locat
multiepitop
region
propos
vaccin
includ
predict
conform
bcell
epitop
tabl
predict
conform
bcell
epitop
depict
fig
furthermor
amino
acid
sequenc
final
propos
vaccin
appli
predict
induc
epitop
use
merci
method
ifnepitop
server
result
show
posit
induc
epitop
score
greater
equal
one
tabl
result
also
reveal
predict
epitop
locat
three
region
includ
relat
ctxb
multiepitop
region
ltiic
respect
bind
affin
interact
propos
vaccin
mhci
ii
molecul
evalu
use
molecular
dock
via
patchdock
server
patchdock
dock
output
list
candid
complex
includ
specifi
receptor
ligand
molecul
rank
base
geometr
shape
complementar
score
approxim
interfac
area
complex
atom
contact
energi
ace
result
molecular
dock
studi
propos
vaccin
mhc
molecul
reveal
propos
vaccin
high
affin
mhci
ii
bestdock
model
vaccinemhci
vaccinemhcii
complex
show
dock
score
respect
furthermor
approxim
interfac
area
mention
complex
found
correspondingli
also
ace
select
top
rank
complex
calcul
high
rank
complex
mhc
molecul
vaccin
select
analysi
molecular
dynam
valid
stabil
vaccinemhc
complex
molecular
dynam
perform
purpos
high
rank
complex
tabl
result
tcell
epitop
predict
labl
sequenc
share
tcell
epitop
mhci
ii
risterect
epitop
share
epitop
high
affin
mhci
mhcii
allel
screen
evalu
total
number
mhci
restrict
epitop
predict
gc
gn
respect
among
share
epitop
select
evalu
mhc
lgcpkipll
form
patchdock
subject
md
simul
first
step
energi
valu
pressur
temperatur
volum
densiti
system
check
equilibr
step
end
simul
result
reveal
md
simul
step
perform
appropri
backbon
rmsd
vaccinemhc
complex
depict
fig
result
demonstr
studi
complex
gradual
increas
backbon
rmsd
ns
system
almost
reach
steadi
state
fact
protein
vaccin
mhc
molecul
tri
get
best
conform
rel
md
simul
radiu
gyrat
import
indic
protein
compact
stabil
therefor
r
g
valu
vaccinemhc
allel
monitor
md
stimul
fig
result
show
r
g
valu
vaccinemhci
mhcii
complex
decreas
significantli
three
four
ns
respect
indic
complex
gain
compact
stabil
md
simul
word
trend
reveal
suitabl
interact
propos
vaccin
mhc
allel
result
final
tcell
epitop
screen
total
number
three
two
tcell
epitop
label
screen
gc
gn
respect
base
antigen
hydrophob
allergen
popul
coverag
gener
predict
epitop
gc
better
properti
gn
deriv
one
protein
tabl
result
linear
bcell
epitop
predict
use
three
differ
server
score
sequenc
similar
consid
determin
factor
comparison
server
output
epitop
select
total
number
three
two
epitop
gc
gn
screen
final
evalu
respect
select
epitop
label
tabl
final
screen
select
linear
bcell
epitop
gc
gn
one
linear
bcell
epitop
antigen
select
final
vaccin
construct
select
epitop
found
good
water
solubl
high
antigen
antigen
score
without
allergen
toxic
potenti
evalu
clone
express
vaccin
within
express
vector
silico
clone
perform
gene
infin
server
amino
acid
sequenc
vaccin
revers
translat
accord
codon
usag
e
coli
express
system
furthermor
design
gene
evalu
term
gccontent
cai
cfd
determin
codon
usag
frequenc
codon
usag
distribut
use
genscript
rare
codon
analysi
tool
result
show
gccontent
cai
cfd
improv
sequenc
found
satisfactori
furthermor
determin
restrict
site
within
optim
dna
xhoi
ndei
restrict
site
creat
dna
respect
follow
ad
six
histidin
residu
end
due
errorpron
natur
cchfv
polymeras
high
infecti
rate
lack
anim
model
develop
vaccin
cchfv
challeng
howev
recent
develop
bioinformat
comput
method
limit
diminish
regard
use
comput
method
epitop
map
design
recombin
protein
evalu
physicochem
properti
well
candid
vaccin
efficaci
avail
therefor
studi
plan
design
effici
multiepitop
recombin
vaccin
cchfv
use
special
multistep
bioinformat
approach
base
best
knowledg
one
studi
comput
design
epitopebas
vaccin
cchf
oani
et
al
identifi
highli
conserv
epitop
rnadepend
rna
polymeras
cchfv
introduc
potenti
epitopebas
vaccin
cchfv
oani
et
al
studi
degre
conserv
consid
determin
factor
along
conserv
factor
immunogen
level
allergen
popul
coverag
physicochem
properti
epitop
must
consid
epitopebas
vaccin
design
mention
paramet
consid
present
studi
furthermor
mention
studi
envelop
glycoprotein
cchfv
also
evalu
determin
conserv
epitop
result
contrari
studi
high
variat
envelop
glycoprotein
observ
variat
focus
n
termin
mucinlik
domain
part
matur
glycoprotein
develop
effici
vaccin
cchf
use
immunoinformat
structur
vaccinolog
strategi
recent
year
strategi
use
design
mani
vaccin
studi
made
modif
common
method
convent
method
select
desir
antigen
epitop
map
perform
evalu
affin
mhc
physicochem
properti
mrna
predict
howev
studi
along
mention
step
multistep
epitop
screen
besid
silico
valid
perform
illustr
fig
propos
multiepitop
vaccin
compos
two
natur
adjuv
ctxb
ltiic
two
bcell
epitop
five
tcell
epitop
merg
appropri
linker
vaccin
construct
analysi
cchfv
virul
factor
gc
gn
glycoprotein
select
main
antigen
sourc
final
band
tcell
epitop
due
high
level
conserv
antigen
gener
viral
glycoprotein
play
vital
role
catalysi
viru
fusion
host
cell
well
assist
invas
consequ
recent
consid
crucial
compon
vaccin
develop
viral
infect
hcv
ebola
viru
human
coronaviru
dengu
viru
mani
other
determin
immunogen
band
tcell
epitop
crucial
step
epitopebas
vaccin
design
tcell
key
role
antibodi
product
polar
antigen
present
viral
infect
accordingli
domin
tcell
epitop
gc
gn
predict
help
multistep
screen
procedur
screen
tcell
epitop
firstli
mhci
restrict
tcell
epitop
predict
next
step
predict
epitop
check
abil
bind
mhcii
allel
primari
screen
tcell
epitop
abil
bind
mhci
ii
select
analysi
final
five
tcell
epitop
screen
base
antigen
popul
coverag
hydrophob
allergen
chowel
et
al
demonstr
hydrophob
hallmark
immunogen
tcell
epitop
mark
step
toward
remov
requir
experiment
epitop
test
vaccin
develop
therefor
studi
first
time
consid
hydrophob
predict
tcell
epitop
determin
factor
epitop
screen
process
bcell
epitop
pivot
role
boost
neutralizingantibodi
respons
differ
infect
consequ
current
identif
bcell
epitop
highli
consid
epitopedriven
vaccin
develop
diagnost
reagent
design
aim
achiev
potent
protect
immun
cchf
two
toprank
linear
bcell
epitop
select
base
antigen
allergen
toxic
hydrophil
screen
band
tcell
epitop
combin
vaccin
construct
final
immunodomin
epitop
use
gpgpgpg
linker
retain
structur
featur
conform
depend
immunogen
epitop
vaccin
besid
variou
advantag
epitopebas
vaccin
weak
low
immunogen
instabl
face
vaccin
platform
seriou
challeng
incorpor
natur
adjuv
epitopebas
vaccin
construct
notabl
diminish
obstacl
henc
merg
immunodomin
epitop
two
natur
adjuv
includ
ctxb
ltiic
n
c
termin
use
eaaak
linker
eaaak
increas
stabil
well
decreas
interact
vaccin
domain
caus
effect
separ
organ
differ
domain
vaccin
physicochem
immunolog
structur
properti
propos
vaccin
evalu
use
differ
bioinformat
tool
result
reveal
vaccin
stabl
watersolubl
nonallergen
highli
antigen
empir
attitud
achiev
highlevel
protein
express
e
coli
key
paramet
cai
gc
cfd
content
gene
optim
gener
gene
cai
rate
good
express
desir
host
gc
content
consid
ideal
percentag
rang
cfd
valu
support
maximum
protein
express
desir
host
mention
paramet
optim
gene
show
propos
vaccin
could
express
effici
e
coli
host
organ
vaccin
element
structur
number
residu
score
predict
use
itass
webserv
primari
structur
subject
refin
process
achiev
highqual
structur
qualiti
refin
model
assign
ramachandran
plot
errat
qualiti
factor
prosa
zscore
result
demonstr
qualiti
refin
model
significantli
improv
sinc
discontinu
bcell
epitop
well
induc
epitop
crucial
role
humor
cellmedi
adapt
immun
respons
produc
antibodi
stimul
macrophag
natur
killer
cell
predict
epitop
current
highli
consid
vaccin
design
subsequ
predict
discontinu
bcell
epitop
induc
epitop
perform
refin
model
subject
predict
input
result
show
residu
residu
vaccin
defin
conform
bcell
epitop
furthermor
result
indic
posit
induc
epitop
vaccin
show
vaccin
provok
strong
antibodi
secret
cellmedi
respons
longrun
protect
cchfv
antigen
present
requir
step
recognit
antigen
immun
system
apc
present
antigen
use
mhc
ii
molecul
accordingli
high
affin
multiepitop
vaccin
mhc
molecul
consid
determin
factor
therefor
evalu
bind
affin
vaccin
mhci
ii
use
molecular
dock
studi
result
confirm
vaccin
high
affin
mhc
molecul
gain
insight
vaccinemhc
interact
evalu
stabil
toprank
complex
vaccinemhci
well
vaccinemhcii
subject
md
stimul
result
confirm
suitabl
stabil
studi
complex
demonstr
persist
interact
mhc
molecul
propos
vaccin
result
studi
show
propos
vaccin
could
consid
good
candid
vitro
vivo
evalu
gener
propos
silico
design
vaccin
candid
vitro
vivo
valid
potenti
toxic
probabl
allergen
crossreact
stabil
determin
effect
dose
total
antibodi
titer
prolifer
lymphocyt
challeng
anim
model
must
done
clarifi
vaccin
efficaci
vaccin
develop
timeconsum
complex
costli
process
simplifi
two
main
stage
includ
preclin
clinic
develop
two
mention
stage
select
right
antigen
vaccin
efficaci
test
tube
anim
formul
safeti
human
use
good
manufactur
practic
standard
immun
tabl
predict
induc
epitop
propos
vaccin
total
number
posit
induc
epitop
score
greater
equal
one
predict
vaccin
amino
acid
residu
vaccin
locat
region
show
highest
score
artifici
infect
clinic
diseas
vaccin
efficaci
natur
diseas
condit
longterm
efficaci
assess
howev
vaccin
develop
time
may
affect
paramet
natur
target
pathogen
equip
facil
avail
technic
manufactur
hurdl
therefor
determin
exact
time
introduc
vaccin
difficult
use
comput
method
silico
valid
requir
time
reduc
due
encourag
result
studi
propos
vaccin
could
synthes
chemic
method
coupl
short
peptid
express
differ
host
bacteria
yeast
mammalian
plant
cell
vitro
vivo
evalu
moreov
efficaci
propos
vaccin
may
improv
use
novel
antigen
deliveri
system
nano
deliveri
platform
conclus
present
studi
indic
computeraid
vaccin
design
could
consid
promis
strategi
acceler
vaccin
develop
highli
pathogen
pathogen
base
method
linear
bcell
tcell
epitop
gc
gn
cchfv
identifi
select
core
multiepitop
recombin
vaccin
cchf
result
studi
suggest
propos
protein
vaccin
stimul
humor
cellular
immun
respons
cchfv
could
serv
potenti
vaccin
cchf
howev
vitro
vivo
immunolog
experi
need
valid
efficaci
vaccin
furthermor
base
promis
result
studi
propos
vaccin
candid
subject
experiment
clone
purif
well
next
vitro
vivo
evalu
vitro
vivo
stabil
toxic
abil
enhanc
total
antibodi
titer
human
lymphocyt
prolifer
creat
immun
infect
